AAAAAA

   
Results: 1-23 |
Results: 23
Comparative genomic hybridization in childhood acute lymphoblastic leukemia: correlation with interphase cytogenetics and loss of heterozygosity analysis
Authors: Scholz, I Popp, S Granzow, M Schoell, B Holtgreve-Grez, H Takeuchi, S Schrappe, M Harbott, J Teigler-Schlegel, A Zimmermann, M Fischer, C Koeffler, HP Bartram, CR Jauch, A
Citation: I. Scholz et al., Comparative genomic hybridization in childhood acute lymphoblastic leukemia: correlation with interphase cytogenetics and loss of heterozygosity analysis, CANC GENET, 124(2), 2001, pp. 89-97
Chromosomal aberrations in sporadic pituitary tumors
Authors: Trautmann, K Thakker, RV Ellison, DW Ibrahim, A Lees, PD Harding, B Fischer, C Popp, S Bartram, CR Jauch, A
Citation: K. Trautmann et al., Chromosomal aberrations in sporadic pituitary tumors, INT J CANC, 91(6), 2001, pp. 809-814
Comparative genomic hybridization analysis in adult T-cell leukemia/lymphoma: correlation with clinical course
Authors: Tsukasaki, K Krebs, J Nagai, K Tomonaga, M Koeffler, HP Bartram, CR Jauch, A
Citation: K. Tsukasaki et al., Comparative genomic hybridization analysis in adult T-cell leukemia/lymphoma: correlation with clinical course, BLOOD, 97(12), 2001, pp. 3875-3881
CD7+ and CD56+ acute myelogenous leukemia is a distinct biologic and clinical disease entity
Authors: Kahl, C Florschutz, A Leuner, S Jentsch-Ullrich, K Franke, A Bartram, CR Hoffkes, HG
Citation: C. Kahl et al., CD7+ and CD56+ acute myelogenous leukemia is a distinct biologic and clinical disease entity, HEMAT BLOOD, 40, 2001, pp. 112-119
Treatment of adult ALL according to protocols of the German Multicenter Study Group for Adult ALL (GMALL)
Authors: Gokbuget, N Hoelzer, D Arnold, R Bohme, A Bartram, CR Freund, M Ganser, A Kneba, M Langer, W Lipp, T Ludwig, WD Maschmeyer, G Rieder, H Thiel, E Weiss, A Messerer, D
Citation: N. Gokbuget et al., Treatment of adult ALL according to protocols of the German Multicenter Study Group for Adult ALL (GMALL), HEMAT ONCOL, 14(6), 2000, pp. 1307
Immunoglobulin kappa gene rearrangements between the kappa deleting element and J kappa recombination signal sequences in acute lymphoblastic leukemia and normal hematopoiesis
Authors: Seriu, T Hansen-Hagge, TE Stark, Y Bartram, CR
Citation: T. Seriu et al., Immunoglobulin kappa gene rearrangements between the kappa deleting element and J kappa recombination signal sequences in acute lymphoblastic leukemia and normal hematopoiesis, LEUKEMIA, 14(4), 2000, pp. 671-674
Digoxigenin-end labeled oligonucleotides facilitate the detection of minimal residual disease in acute lymphoblastic leukemia
Authors: Nakao, M Janssen, JWG Schafer, M Bartram, CR
Citation: M. Nakao et al., Digoxigenin-end labeled oligonucleotides facilitate the detection of minimal residual disease in acute lymphoblastic leukemia, LEUKEMIA, 14(4), 2000, pp. 767-768
Tandem duplication of the FLT3 gene in acute lymphoblastic leukemia: a marker for the monitoring of minimal residual disease
Authors: Nakao, M Janssen, JWG Erz, D Seriu, T Bartram, CR
Citation: M. Nakao et al., Tandem duplication of the FLT3 gene in acute lymphoblastic leukemia: a marker for the monitoring of minimal residual disease, LEUKEMIA, 14(3), 2000, pp. 522-524
Rapid and reliable detection of N-ras mutations in acute lymphoblastic leukemia by melting curve analysis using LightCycler technology
Authors: Nakao, M Janssen, JWG Seriu, T Bartram, CR
Citation: M. Nakao et al., Rapid and reliable detection of N-ras mutations in acute lymphoblastic leukemia by melting curve analysis using LightCycler technology, LEUKEMIA, 14(2), 2000, pp. 312-315
Molecular detection of minimal residual disease is a strong predictive factor of relapse in childhood B-lineage acute lymphoblastic leukemia with medium risk features. A case control study of the International BFM study group
Authors: Biondi, A Valsecchi, MG Seriu, T D'Aniello, E Willemse, MJ Fasching, K Pannunzio, A Gadner, H Schrappe, M Kamps, WA Bartram, CR van Dongen, JJM Panzer-Grumayer, ER
Citation: A. Biondi et al., Molecular detection of minimal residual disease is a strong predictive factor of relapse in childhood B-lineage acute lymphoblastic leukemia with medium risk features. A case control study of the International BFM study group, LEUKEMIA, 14(11), 2000, pp. 1939-1943
Duplex PCR facilitates the identification of immunoglobulin kappa (IGK) gene rearrangements in acute lymphoblastic leukemia
Authors: Nakao, M Janssen, JWG Bartram, CR
Citation: M. Nakao et al., Duplex PCR facilitates the identification of immunoglobulin kappa (IGK) gene rearrangements in acute lymphoblastic leukemia, LEUKEMIA, 14(1), 2000, pp. 218-219
Rapid and reliable quantification of minimal residual disease in acute lymphoblastic leukemia using rearranged immunoglobulin and T-cell receptor loci by LightCycler technology
Authors: Nakao, M Janssen, JWG Flohr, T Bartram, CR
Citation: M. Nakao et al., Rapid and reliable quantification of minimal residual disease in acute lymphoblastic leukemia using rearranged immunoglobulin and T-cell receptor loci by LightCycler technology, CANCER RES, 60(12), 2000, pp. 3281
Concurrent activation of a novel putative transforming gene, myeov, and cyclin D1 in a subset of multiple myeloma cell lines with t(11;14)(q13;q32)
Authors: Janssen, JWG Vaandrager, JW Heuser, T Jauch, A Kluin, PM Geelen, E Bergsagel, PL Kuehl, WM Drexler, HG Otsuki, T Bartram, CR Schuuring, E
Citation: Jwg. Janssen et al., Concurrent activation of a novel putative transforming gene, myeov, and cyclin D1 in a subset of multiple myeloma cell lines with t(11;14)(q13;q32), BLOOD, 95(8), 2000, pp. 2691-2698
Mutations of the E2F4 gene in hematological malignancies having microsatellite instability
Authors: Komatsu, N Takeuchi, S Ikezoe, T Tasaka, T Hatta, Y Machida, H Williamson, IK Bartram, CR Koeffler, HP Taguchi, H
Citation: N. Komatsu et al., Mutations of the E2F4 gene in hematological malignancies having microsatellite instability, BLOOD, 95(4), 2000, pp. 1509-1510
Identification of a novel putative Ran-binding protein and its close homologue
Authors: Koch, P Bohlmann, I Schafer, M Hansen-Hagge, TE Kiyoi, H Wilda, M Hameister, H Bartram, CR Janssen, JWG
Citation: P. Koch et al., Identification of a novel putative Ran-binding protein and its close homologue, BIOC BIOP R, 278(1), 2000, pp. 241-249
Identification of three distinct regions of deletion on the long arm of chromosome 11 in childhood acute lymphoblastic leukemia
Authors: Takeuchi, S Cho, SK Seriu, T Koike, M Bartram, CR Reiter, A Schrappe, M Takeuchi, C Taguchi, H Koeffler, HP
Citation: S. Takeuchi et al., Identification of three distinct regions of deletion on the long arm of chromosome 11 in childhood acute lymphoblastic leukemia, ONCOGENE, 18(51), 1999, pp. 7387-7388
Mutational analysis of the Hel-N1 gene in childhood acute lymphoblastic leukemia with LOH at 9p21
Authors: Takeuchi, C Takeuchi, S Ikezoe, T Bartram, CR Koeffler, HP Taguchi, H
Citation: C. Takeuchi et al., Mutational analysis of the Hel-N1 gene in childhood acute lymphoblastic leukemia with LOH at 9p21, LEUKEMIA, 13(4), 1999, pp. 650-651
Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptorgene rearrangements and TAL1 deletions as PCR targets - Report of the BIOMED-1 CONCERTED ACTION: Investigation of minimal residual disease in acute leukemia
Authors: Pongers-Willemse, MJ Seriu, T Stolz, F d'Aniello, E Gameiro, P Pisa, P Gonzalez, M Bartram, CR Panzer-Grumayer, ER Biondi, A San Miguel, JF van Dongen, JJM
Citation: Mj. Pongers-willemse et al., Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptorgene rearrangements and TAL1 deletions as PCR targets - Report of the BIOMED-1 CONCERTED ACTION: Investigation of minimal residual disease in acute leukemia, LEUKEMIA, 13(1), 1999, pp. 110-118
Molecular diagnosis of type 1c glycogen storage disease
Authors: Janecke, AR Bosshard, NU Mayatepek, E Schulze, A Gitzelmann, R Burchell, A Bartram, CR Janssen, B
Citation: Ar. Janecke et al., Molecular diagnosis of type 1c glycogen storage disease, HUM GENET, 104(3), 1999, pp. 275-277
Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood - Reply
Authors: van Dongen, JJM Pongers-Willemse, MJ Biondi, A Panzer-Grumayer, ER Bartram, CR
Citation: Jjm. Van Dongen et al., Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood - Reply, LANCET, 353(9154), 1999, pp. 752-753
Spectrum of transforming sequences detected by tumorigenicity assay in a large series of human neoplasms
Authors: Janssen, JWG Braunger, J Ballas, K Faust, M Siebers, U Steenvoorden, ACM Bartram, CR
Citation: Jwg. Janssen et al., Spectrum of transforming sequences detected by tumorigenicity assay in a large series of human neoplasms, INT J CANC, 80(6), 1999, pp. 857-862
Loss of p73 gene expression in leukemias/lymphomas due to hypermethylation
Authors: Kawano, S Miller, CW Gombart, AF Bartram, CR Matsuo, Y Asou, H Sakashita, A Said, J Tatsumi, E Koeffler, HP
Citation: S. Kawano et al., Loss of p73 gene expression in leukemias/lymphomas due to hypermethylation, BLOOD, 94(3), 1999, pp. 1113-1120
Mutations in the gene for the common gamma chain (gamma(c)) in X-linked severe combined immunodeficiency
Authors: Fugmann, SD Muller, S Friedrich, W Bartram, CR Schwarz, K
Citation: Sd. Fugmann et al., Mutations in the gene for the common gamma chain (gamma(c)) in X-linked severe combined immunodeficiency, HUM GENET, 103(6), 1998, pp. 730-731
Risultati: 1-23 |